Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Nanalysis develops and manufactures compact MRI and NMR devices for clinical, laboratory, and industrial markets. These portable devices require no liquid helium or any other cryogens. The company’s devices are used in diagnostics and chemical analysis across a range of industries (medical, pharma, biotech, mining, oil and gas, and more) as well as numerous government and university research labs around the world.


TSXV:NSCI - Post by User

Post by Oilytrader1on Jan 23, 2022 4:54pm
197 Views
Post# 34350371

DD question

DD questionGood day,

I have come across Nanalysis through a "pricing power" transcript screen, totally random. However, I actually really like what i see on the surface, like really really like it. 

They are disrupting a traditional industry through democatization, and are opening up new markets in the process with IP as well.

Hoping an intelligent existing shareholder can answer a few questions:

1) With the planned capacity additions, what is a reasonable revenue growth profile for FY22, FY23' based on existing backlog + reasonable new orders?

2) Why did they announce an NCIB on Oct 21st stating they thought shares were under-valued at prevailing prices of ~$1.20, then do a best-efforts offering @ $1.10 only 3 months later? 
2a) Does the CFO know what he is doing? 
2b) Did he actually execute on the NCIB @ prices higher than the marketed offering of $1.10?
2c) Are there other wierd finance activities that have caught you off-guard in the past?

3) Who are the main competitors? Do they have a comparable product? Is this technology essentially superior to any incumbent products that industries may use today?

4) What is your experience in dealing with Investor Relations department ? Are they timely in response, do they provide valueable feedback?

5) What is your blue-sky target over a 3-5 year timeframe? 

Thanks for any response to these questions, Oily.
<< Previous
Bullboard Posts
Next >>